| 000 | 01682 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513191142.0 | ||
| 264 | 0 | _c19990915 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a1058-4838 | ||
| 024 | 7 |
_a10.1086/514775 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMayer, K H | |
| 245 | 0 | 0 |
_aPersistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJun 1999 |
||
| 300 |
_a1252-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aDNA, Viral _xanalysis |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Protease _xgenetics |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndinavir _xadministration & dosage |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRNA, Viral _xanalysis |
| 650 | 0 | 4 |
_aSemen _xvirology |
| 700 | 1 | _aBoswell, S | |
| 700 | 1 | _aGoldstein, R | |
| 700 | 1 | _aLo, W | |
| 700 | 1 | _aXu, C | |
| 700 | 1 | _aTucker, L | |
| 700 | 1 | _aDePasquale, M P | |
| 700 | 1 | _aD'Aquila, R | |
| 700 | 1 | _aAnderson, D J | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 28 _gno. 6 _gp. 1252-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/514775 _zAvailable from publisher's website |
| 999 |
_c10408853 _d10408853 |
||